NASDAQ:CLRB

Cellectar Biosciences Stock Predictions

etoro logo Buy CLRB
*Your capital is at risk
$2.60
-0.140 (-5.11%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CLRB Prediction Chart

CLRB Predictions History

Latest community submissions for CLRB.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Mar 16, 2017 $2.52 -98.95% $2.39 V 94.60% 0
JS JS Pro
Mar 6, 2017 $2.27 -99.05% $2.38 X 95.40% 0
JS JS Pro
Mar 1, 2017 $2.16 -99.04% $2.25 V 96.00% 0
Devert Devert @Devert.3418
Mar 1, 2017 $1.90 -99.16% $2.25 V 84.40% 0
Brian Brian @Brian.3419
Mar 1, 2017 $2.06 -99.08% $2.25 V 91.60% 0
Mar 1, 2017 $2.10 -99.07% $2.25 V 93.30% 0
Feb 23, 2017 $2.53 -98.85% $2.20 V 85.00% 0
JS JS Pro
Feb 23, 2017 $2.34 -98.94% $2.20 V 93.60% 0
Feb 23, 2017 $2.18 -99.01% $2.20 V 99.10% 1
turki turki @turki.1507
Feb 21, 2017 $2.35 -99.09% $2.59 V 90.70% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CLRB with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CELLECTAR BIOSCIENCES
Cellectar Biosciences
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE